GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Milestone Scientific Inc (AMEX:MLSS) » Definitions » Piotroski F-Score
中文

Milestone Scientific (Milestone Scientific) Piotroski F-Score

: 3 (As of Today)
View and export this data going back to 1995. Start your Free Trial

Warning Sign:

Piotroski F-Score of 3 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Milestone Scientific has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Milestone Scientific's Piotroski F-Score or its related term are showing as below:

MLSS' s Piotroski F-Score Range Over the Past 10 Years
Min: 2   Med: 3   Max: 5
Current: 3

During the past 13 years, the highest Piotroski F-Score of Milestone Scientific was 5. The lowest was 2. And the median was 3.


Milestone Scientific Piotroski F-Score Historical Data

The historical data trend for Milestone Scientific's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Milestone Scientific Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.00 3.00 4.00 2.00 3.00

Milestone Scientific Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.00 2.00 3.00 3.00 3.00

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Milestone Scientific's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Milestone Scientific Piotroski F-Score Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Milestone Scientific's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Milestone Scientific's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Net Income was -1.308 + -2.216 + -1.466 + -1.939 = $-6.93 Mil.
Cash Flow from Operations was -2.004 + -1.024 + -1.053 + -1.246 = $-5.33 Mil.
Revenue was 2.598 + 2.91 + 2.059 + 2.261 = $9.83 Mil.
Gross Profit was 1.889 + 1.89 + 1.503 + 1.51 = $6.79 Mil.
Average Total Assets from the begining of this year (Dec22)
to the end of this year (Dec23) was
(13.702 + 12.273 + 11.151 + 10.584 + 11.372) / 5 = $11.8164 Mil.
Total Assets at the begining of this year (Dec22) was $13.70 Mil.
Long-Term Debt & Capital Lease Obligation was $0.28 Mil.
Total Current Assets was $10.79 Mil.
Total Current Liabilities was $3.08 Mil.
Net Income was -1.902 + -2.858 + -1.972 + -1.974 = $-8.71 Mil.

Revenue was 2.701 + 1.648 + 2.216 + 2.241 = $8.81 Mil.
Gross Profit was 1.682 + 0.681 + 1.453 + 1.085 = $4.90 Mil.
Average Total Assets from the begining of last year (Dec21)
to the end of last year (Dec22) was
(19.81 + 19.065 + 16.512 + 15.278 + 13.702) / 5 = $16.8734 Mil.
Total Assets at the begining of last year (Dec21) was $19.81 Mil.
Long-Term Debt & Capital Lease Obligation was $0.40 Mil.
Total Current Assets was $12.97 Mil.
Total Current Liabilities was $3.30 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Milestone Scientific's current Net Income (TTM) was -6.93. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Milestone Scientific's current Cash Flow from Operations (TTM) was -5.33. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Dec22)
=-6.929/13.702
=-0.5056926

ROA (Last Year)=Net Income/Total Assets (Dec21)
=-8.706/19.81
=-0.43947501

Milestone Scientific's return on assets of this year was -0.5056926. Milestone Scientific's return on assets of last year was -0.43947501. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Milestone Scientific's current Net Income (TTM) was -6.93. Milestone Scientific's current Cash Flow from Operations (TTM) was -5.33. ==> -5.33 > -6.93 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Dec23)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec22 to Dec23
=0.282/11.8164
=0.02386514

Gearing (Last Year: Dec22)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Dec21 to Dec22
=0.396/16.8734
=0.02346889

Milestone Scientific's gearing of this year was 0.02386514. Milestone Scientific's gearing of last year was 0.02346889. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Dec23)=Total Current Assets/Total Current Liabilities
=10.794/3.077
=3.5079623

Current Ratio (Last Year: Dec22)=Total Current Assets/Total Current Liabilities
=12.971/3.3
=3.93060606

Milestone Scientific's current ratio of this year was 3.5079623. Milestone Scientific's current ratio of last year was 3.93060606. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Milestone Scientific's number of shares in issue this year was 73.979. Milestone Scientific's number of shares in issue last year was 70.987. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=6.792/9.828
=0.69108669

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=4.901/8.806
=0.55655235

Milestone Scientific's gross margin of this year was 0.69108669. Milestone Scientific's gross margin of last year was 0.55655235. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Dec22)
=9.828/13.702
=0.71726755

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Dec21)
=8.806/19.81
=0.44452297

Milestone Scientific's asset turnover of this year was 0.71726755. Milestone Scientific's asset turnover of last year was 0.44452297. ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+0+0+0+1+1
=3

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Milestone Scientific has an F-score of 3. It is a bad or low score, which usually implies poor business operation.

Milestone Scientific  (AMEX:MLSS) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Milestone Scientific Piotroski F-Score Related Terms

Thank you for viewing the detailed overview of Milestone Scientific's Piotroski F-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Milestone Scientific (Milestone Scientific) Business Description

Traded in Other Exchanges
N/A
Address
425 Eagle Rock Avenue, Roseland, NJ, USA, 07068
Milestone Scientific Inc is engaged in pioneering proprietary, technological systems, and solutions for the medical and dental markets. It develops, manufactures, markets and sells the computer-controlled system for the improved and painless delivery of local anesthetic. The system is marketed in dentistry under the trademark CompuDent and in medicine under the trademark CompuMed. In addition, the company provides The Wand, a handpiece that allows dentists to provide painless injections for virtually various dental procedures, including routine cleanings and fillings, as well as implants, root canals, and crowns. The Company conducts its business through two reportable segments: Dental and Medical. Geographically all the operations of the firm function through the region of the U.S.
Executives
Peter J Milligan officer: President 1650 TYSONS BOULEVARD, SUITE 1700, MCLEAN VA 22102
Neal I Goldman director 170 SOUTHPORT DRIVE, MORRISVILLE NC 27560
Leslie Bernhard director C/O ADSTAR, INC., 488 S. ROYAL LANE, COPPELL TX 75019
Benedetta I Casamento director 200 CAMPUS DRIVE, FLORHAM PARK NJ 07932
Leonard Osser director, 10 percent owner, officer: CEO
Leonard M Schiller director
Scott L. Kahn officer: Chief Financial Officer 425 EAGLE ROCK AVENUE, SUITE 403, ROSELAND NJ 07068
Giandomenico Trombetta director, 10 percent owner CORSO VENEZIA 44, MILAN L6 20121
Joseph D'agostino officer: CFO & COO C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE, LIVINGSTON NJ 07039
Jan Adriaan Haverhals officer: President 110 WHITE ROCK ROAD, APT. 3304, VERONA NJ 07044
Brent W Johnston officer: President C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE SUITE 102, LIVINGSTON NJ 07039
Michael Mcgeehan director C/O MILESTONE SCIENTIFIC INC, LIVINGSTON NJ 07039
Edward J. Zelnick director C/O MILESTONE SCIENTIFIC INC., 220 SOUTH ORANGE AVENUE, LIVINGSTON NJ 07039
Daniel S Goldberger officer: President and CEO 24 CARPENTER ROAD, CHESTER NY 10918
Bp4 S.r.l. director, 10 percent owner, officer: See Remarks CORSO VENEZIA 44, MILAN L6 20121

Milestone Scientific (Milestone Scientific) Headlines